Almonty's Buyback Shrinks the Share Count While a Canadian Court Weighs Its Claims
Published on 11/20/2026 at 12:41 | Editorial boerse-global.deAlmonty spent the third quarter of 2026 buying back its own stock, and the timing is what makes the move worth a second look. The repurchases landed in the same stretch that produced the company's first tungsten concentrate from Sangdong — a juxtaposition that frames the central question for investors: how much weight should a buyback carry while the path from production to delivery is still being mapped?
The market has been in a selling mood regardless. The stock shed 2.8% on Thursday and has given up 7.8% over the past seven sessions, with a further 2.4% decline logged on a separate trading day.
What the Repurchase Actually Does
On November 12, Almonty disclosed that it had bought back and cancelled 2,914,739 shares during Q3 2026, at a weighted average price of US$16.58 per share. The company kept buying after the quarter closed as well.
Cancelling repurchased stock reduces the share count. On its own, though, it says little about what the operating business can generate going forward. That is the distinction between a capital measure and progress at Sangdong: the buyback changes how many pieces the pie is cut into, while the mine's development determines what those pieces are actually worth.
Should investors sell immediately? Or is it worth buying Almonty?
Sangdong's First Steps Toward Delivery
Sangdong poured its first tungsten concentrate in September. After the quarter ended, the inaugural container was loaded in Busan for shipment abroad — concrete movement from production toward delivery. Loading a single container, however, is not yet a yardstick for how much concentrate Sangdong can supply on a regular basis.
For Q3 2026, Almonty reported revenue of C$41.9 million and adjusted EBITDA of C$14.6 million. Those are group-level figures, so they should not be read as a proxy for what Sangdong can contribute in steady-state operation. Net income of C$50.2 million included C$47.9 million in non-cash revaluation gains. According to Almonty, more than 90% of Phase I production at Sangdong is contractually committed.
Legal Front: Claims, Counterclaims and a Consolidated Case
Deutsche Rohstoff, in its quarterly report on Tuesday, put its claims against Almonty at roughly USD 67 million. It had announced on November 11 that it filed suit in Canada, seeking 3.5 million shares from a conversion as well as repayment of liabilities totaling around EUR 10 million. Almonty's counterclaim targets the 2014 sale of Wolfram Camp. Both proceedings have been consolidated, according to Deutsche Rohstoff.
Almonty at a turning point? This analysis reveals what investors need to know now.
A Lower Target, an Unchanged Verdict
B. Riley cut its price target to US$18 from US$20 on November 16 while reaffirming its buy rating. The research house pointed to the timing of deliveries from Sangdong and anticipated a smaller contribution in Q4 2026. The same day, Almonty announced it is pursuing a secondary listing on the Korea Exchange.
The trimmed target alongside the intact recommendation shows that valuation can shift without the analyst house reversing its directional call. The Korean listing concerns access to capital markets; the buyback concerns the number of shares outstanding. For judging operations, a different measure matters more: whether the first loaded container becomes a pattern of regular shipments.
Ad
Almonty Stock: New Analysis - 20 November
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
